Media & Resources

Scientific Publications

An influenza vaccine pill can we swallow it

Scientific Publications

HLA Class II Associated HIV Polymorphisms Predict Escape from CD4 T Cell Responses

Scientific Publications

High Transmitter CD4 T Cell Count Shortly after the Time of Transmission in a Study of African Serodiscordant Couples

Press Releases

IAVI Names Dr. Mark Feinberg New President and CEO

August 12, 2015

NEW YORK – AUGUST 12, 2015 – The Board of Directors of the International AIDS Vaccine Initiative (IAVI) announced today that Mark Feinberg, MD, PhD, has been appointed IAVI’s new President and CEO, effective 8 September 2015. “Mark brings a wealth of relevant experience and the passion to lead IAVI through the next chapter of…

Scientific Publications

A Phase I Double Blind Placebo Controlled Randomized Study of the Safety and Immunogenicity of Electroporated HIV DNA with or without Interleukin 12 in Prime Boost Combinations with an Ad35 HIV Vaccine in Healthy HIV Seronegative African Adults

Scientific Publications

Canine distemper virus neutralization activity is low in human serum and it is sensitive to an amino acid substitution in the hemagglutinin protein

Press Releases

IAVI Programs Help Strengthen East Africa’s Health Research Capacity

July 30, 2015

NEW YORK – The International AIDS Vaccine Initiative (IAVI) has made significant contributions to strengthening health research systems in East Africa, according to a study published by RAND Europe on 30 July. In order to develop effective AIDS vaccines for use throughout the world, it is essential to build partnerships and bolster capacity to conduct…

Press Releases

AIDS Vaccine R&D Funding – Latest Data Shows Concerning Trends

July 17, 2015

NEW YORK – The latest data from the HIV Vaccines and Microbicides Resource Tracking Working Group highlights concerning trends in funding for vaccine-related research and development. Among the report’s key findings: There’s a flat trend in AIDS vaccine R&D investment. While funding for crucial HIV treatment and prevention programs in low- and middle-income countries is…

1…133 134135136 137…233 of 233

Media & Resources

Filter by

Type

Health area

Location

Topic

Year

Journal

Publication

Fact sheet & publication type

An influenza vaccine pill can we swallow it

HLA Class II Associated HIV Polymorphisms Predict Escape from CD4 T Cell Responses

High Transmitter CD4 T Cell Count Shortly after the Time of Transmission in a Study of African Serodiscordant Couples

IAVI Names Dr. Mark Feinberg New President and CEO

A Phase I Double Blind Placebo Controlled Randomized Study of the Safety and Immunogenicity of Electroporated HIV DNA with or without Interleukin 12 in Prime Boost Combinations with an Ad35 HIV Vaccine in Healthy HIV Seronegative African Adults

Canine distemper virus neutralization activity is low in human serum and it is sensitive to an amino acid substitution in the hemagglutinin protein

IAVI Programs Help Strengthen East Africa’s Health Research Capacity

AIDS Vaccine R&D Funding – Latest Data Shows Concerning Trends

Media & Resources

Filter by

Type

Health area

Location

Topic

Year

Journal

Publication

Fact sheet & publication type

An influenza vaccine pill can we swallow it

HLA Class II Associated HIV Polymorphisms Predict Escape from CD4 T Cell Responses

High Transmitter CD4 T Cell Count Shortly after the Time of Transmission in a Study of African Serodiscordant Couples

IAVI Names Dr. Mark Feinberg New President and CEO

A Phase I Double Blind Placebo Controlled Randomized Study of the Safety and Immunogenicity of Electroporated HIV DNA with or without Interleukin 12 in Prime Boost Combinations with an Ad35 HIV Vaccine in Healthy HIV Seronegative African Adults

Canine distemper virus neutralization activity is low in human serum and it is sensitive to an amino acid substitution in the hemagglutinin protein

IAVI Programs Help Strengthen East Africa’s Health Research Capacity

AIDS Vaccine R&D Funding – Latest Data Shows Concerning Trends

Subscription Type